Connor, Clark & Lunn Investment Management (CC&L)’s Galectin Therapeutics GALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,611
| Closed | -$37.5K | – | 1517 |
|
|
2024
Q2 | $37.5K | Buy |
+16,611
| New | +$37.5K | ﹤0.01% | 1334 |
|
|
2023
Q4 | – | Sell |
-10,049
| Closed | -$19.3K | – | 1446 |
|
|
2023
Q3 | $19.3K | Sell |
10,049
-5,884
| -37% | -$11.3K | ﹤0.01% | 1330 |
|
|
2023
Q2 | $22.9K | Buy |
+15,933
| New | +$22.9K | ﹤0.01% | 1283 |
|